Learn from survivors and caregivers what it's like to live with kidney cancer. Then, read the companion book to this video series, "We Have Kidney Cancer: Survivor Stories," available for purchase on Amazon.com or as a FREE PDF from KidneyCancer.org.

This week, Paula Busse, MD, an associate professor of medicine at the Icahn School of Medicine at Mount Sinai, discusses results from her trial of an innovative drug to fight angioedema, a chronic swelling disorder. Also, Ketan Badani, MD, vice chair of urology and robotic operations for the Mount Sinai Health System, provides an overview of Kidney Cancer Awareness Month and ongoing kidney cancer-related research at Mount Sinai.

Treatment options for small renal masses include radical nephrectomy, partial nephrectomy as well as thermal ablation. The following educational video aims at helping one understand the principles of RFA and needle ablation for small renal tumours. This should be discussed during informed consent of patients with small renal masses (along with active surveillance, partial nephrectomy and radical nephrectomy) seeking treatment.

Dr. Robert Sachner of Bnai Zion Medical Center in Haifa, Israel performs percutaneous cryoablation of kidney tumors using the ProSense Cryoablation System by IceCure Medical

Studies of patients with kidney cancer have shown that radiofrequency ablation, a minimally invasive, kidney-sparing procedure, can be a successful treatment option for patients whose cancer has not spread beyond the kidney.

The treatment uses computed tomography for guidance during percutaneous placement of a needle-shaped electrode into the tumor. Radiofrequency current is then passed through the electrode to heat the tumor tissue and ablate -- or eliminate -- it.